Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT01689064 : Comparison of Surgical Approach to Endoscopic Pituitary Adenoma Resection
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Age > 18 years old

- Diagnosis of a pituitary adenoma requiring resection defined as pituitary lesion with
any of the following:

1. Neuroimaging or clinical evidence of apoplexy

2. Decline in central visual acuity worse than (best-corrected) Snellen equivalent
of 20/25 in either eye

3. clinically significant visual field loss as determined by Humphrey or Goldmann
perimetry

4. Clinically significant cranial nerve deficit

5. Clinically relevant neuroendocrine deficit

6. Intolerance of optimal medical management

- Patient electing endoscopic resection approach

Exclusion Criteria:

- Concurrent chronic rhinosinusitis

- Revision pituitary adenoma resections

- Severe medical co-morbidities with the inability to undergo general anesthesia
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT01689064      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740